Search research articles
Contact Us
Filters
Showing results (11-20 of 82) with videos related to
Page
of 9
Sort By:
European Neurology
|
November 17, 2011
Economic burden in a German cohort of patients with multiple sclerosis
Jens Peter Reese, Axel John, Gabriele Wienemann, et al.
Plos One
|
February 13, 2016
Increased Frequency of T Follicular Helper Cells and Elevated Interleukin-27 Plasma Levels in Patients with Pemphigus
Tina Hennerici, Robert Pollmann, Thomas Schmidt, et al.
Journal of Neuroimmunology
|
January 8, 2018
Serum titers of autoantibodies against α-synuclein and tau in child- and adulthood
Isabell Kuhn, Tobias Rogosch, Theresa I Schindler, et al.
Muscle & Nerve
|
April 9, 2014
Intravenous immunoglobulin maintenance treatment in myasthenia gravis: a randomized, controlled trial sample size simulation
Christian Eienbröker, Florian Seitz, Anna Spengler, et al.
Muscle & Nerve
|
April 15, 2026
Quality of Life in Patients With Chronic Inflammatory Demyelinating Polyneuropathy
Tobias C Blum, Hendrik van der Wurp, David Mengel, et al.
Plos One
|
March 14, 2013
Myasthenia gravis: analysis of serum autoantibody reactivities to 1827 potential human autoantigens by protein macroarrays
Anne Becker, Nicole Ludwig, Andreas Keller, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics
|
December 24, 2017
Clinical and Demographic Profile of Patients Receiving Fingolimod in Clinical Practice in Germany and the Benefit-Risk Profile of Fingolimod After 1 Year of Treatment: Initial Results From the Observational, Noninterventional Study PANGAEA
Tjalf Ziemssen, Michael Lang, Björn Tackenberg, et al.
Seizure
|
January 11, 2011
Cytokines and epilepsy
Gang Li, Sebastian Bauer, Mareike Nowak, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
May 21, 2014
Predictors for multiple sclerosis relapses after switching from natalizumab to fingolimod
Robert Hoepner, Joachim Havla, Christian Eienbröker, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
February 27, 2013
Natalizumab treatment decreases serum IgM and IgG levels in multiple sclerosis patients
Rebecca C Selter, Viola Biberacher, Verena Grummel, et al.
Page
of 9
Search research articles
Search
Showing results (11-20 of 82) with videos related to
Sort By:
Page
of 9
European Neurology
|
November 17, 2011
Economic burden in a German cohort of patients with multiple sclerosis
Jens Peter Reese, Axel John, Gabriele Wienemann, et al.
Plos One
|
February 13, 2016
Increased Frequency of T Follicular Helper Cells and Elevated Interleukin-27 Plasma Levels in Patients with Pemphigus
Tina Hennerici, Robert Pollmann, Thomas Schmidt, et al.
Journal of Neuroimmunology
|
January 8, 2018
Serum titers of autoantibodies against α-synuclein and tau in child- and adulthood
Isabell Kuhn, Tobias Rogosch, Theresa I Schindler, et al.
Muscle & Nerve
|
April 9, 2014
Intravenous immunoglobulin maintenance treatment in myasthenia gravis: a randomized, controlled trial sample size simulation
Christian Eienbröker, Florian Seitz, Anna Spengler, et al.
Muscle & Nerve
|
April 15, 2026
Quality of Life in Patients With Chronic Inflammatory Demyelinating Polyneuropathy
Tobias C Blum, Hendrik van der Wurp, David Mengel, et al.
Plos One
|
March 14, 2013
Myasthenia gravis: analysis of serum autoantibody reactivities to 1827 potential human autoantigens by protein macroarrays
Anne Becker, Nicole Ludwig, Andreas Keller, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics
|
December 24, 2017
Clinical and Demographic Profile of Patients Receiving Fingolimod in Clinical Practice in Germany and the Benefit-Risk Profile of Fingolimod After 1 Year of Treatment: Initial Results From the Observational, Noninterventional Study PANGAEA
Tjalf Ziemssen, Michael Lang, Björn Tackenberg, et al.
Seizure
|
January 11, 2011
Cytokines and epilepsy
Gang Li, Sebastian Bauer, Mareike Nowak, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
May 21, 2014
Predictors for multiple sclerosis relapses after switching from natalizumab to fingolimod
Robert Hoepner, Joachim Havla, Christian Eienbröker, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
February 27, 2013
Natalizumab treatment decreases serum IgM and IgG levels in multiple sclerosis patients
Rebecca C Selter, Viola Biberacher, Verena Grummel, et al.
Page
of 9